UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014803
Receipt number R000017216
Scientific Title Predictors of hemodynamic compromise after rapid pacing for valve deployment during transcatheter aortic valve implantation
Date of disclosure of the study information 2014/08/09
Last modified on 2014/08/09 12:43:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Predictors of hemodynamic compromise after rapid pacing for valve deployment during transcatheter aortic valve implantation

Acronym

Predictors of hemodynamic compromise after rapid pacing for valve deployment during TAVI

Scientific Title

Predictors of hemodynamic compromise after rapid pacing for valve deployment during transcatheter aortic valve implantation

Scientific Title:Acronym

Predictors of hemodynamic compromise after rapid pacing for valve deployment during TAVI

Region

Japan


Condition

Condition

severe aortic stenosis

Classification by specialty

Anesthesiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Although the gold standard of treatment for severe aortic stenosis (AS) is surgical aortic valve replacement (AVR), AVR has not been applicable for patients at high risk because AVR, which requires cardiopulmonary bypass (CPB) and cardiac arrest, is too invasive to such patients.
Transcatheter aortic valve implantation (TAVI) is a treatment for severe AS practically applyng catheter technique. TAVI is thought as less invasive than AVR because it does not require CPB, and is widely recognized as feasible treatment for AS patiets at high risk.
However some procedures of TAVI provoke hemodynamic unstability. The representive one is rapid pacing (RP), which causes severe hemodynamic compromise because it is induced in order to limit cardiac ejection by artificial tachycardia (160~220 beat per minute) for precise completion of valve deployment. During RP, blood pressure drops down extremely because blood flow almost stops. Althpugh hemodynamics will recover after RP, some cases suffers from hemodynamic compromise with long duration. Thus, it is important to identify factors which predicts hemidynamic compromise ofter RP, there was no report about this.
We will retrospectively observe systemic blood pressure and mixed venous oximetry (SvO2) as index of systemic oxygen balances, and then investigate the factors which influenced the recovery of blood pressure and SvO2 after RP for valve deployment.

Basic objectives2

Others

Basic objectives -Others

We will identify factors, which predict hemodynamic compromise after rapid pacing for valve delployment during TAVI, from preoperative data and intraoperative hemodynamic parameters.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of factors which predict hemodynamic compromise after rapid pacing for valve delployment during TAVI

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with severe AS undergoing TAVI

Key exclusion criteria

Cases in which mechanical circulatory support were induced electively or emergenty during the operations

Target sample size

44


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Iritakenishi

Organization

Osaka University Graduate School of Medicine

Division name

Department of Anesthesiology and Intensive Care Medicine

Zip code


Address

2-2 Yamada-oka, 2-2 Suita Osaka 565-0871, Japan

TEL

06-6879-3133

Email

iritake@anes.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Iritakenishi

Organization

Osaka University Graduate School of Medicine

Division name

Department of Anesthesiology and Intensive Care Medicine

Zip code


Address

2-2 Yamada-oka, 2-2 Suita Osaka 565-0871, Japan

TEL

06-6879-3133

Homepage URL


Email

iritake@anes.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Graduate School of Medicine
Department of Anesthesiology and Intensive Care Medicine

Institute

Department

Personal name



Funding Source

Organization

Osaka University Graduate School of Medicine
Department of Anesthesiology and Intensive Care Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 08 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 21 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 21 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multiple logistic analysis identified only SvO2 before RP as the significantly independent factor of the delayed recovery of hemodynamics after RP . Receiver operating characteristic (ROC) curves analysis showed that two groups ware discriminated by SvO2 of 67% a sensitivity of 82% and a specificity of 85% .


Management information

Registered date

2014 Year 08 Month 09 Day

Last modified on

2014 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017216


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name